Welcome
Support Centre
30 July 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Total or Partial Knee Arthroplasty Trial
ISRCTN ISRCTN03013488
ClinicalTrials.gov identifier
Public title Total or Partial Knee Arthroplasty Trial
Scientific title Clinical and cost-effectiveness of total knee replacements versus partial knee replacements for patients with medial compartment osteoarthritis: a multicentre randomised controlled trial
Acronym TOPKAT
Serial number at source HTA 08/14/08; Version 1
Study hypothesis To assess the clinical and cost-effectiveness of total knee replacements versus partial knee replacements for patients with medial compartment osteoarthritis.

Please note that, as of 17/09/2009, the start and end dates of this trial have been updated from 01/06/2009 and 01/06/2023 to 01/11/2009 and 31/10/2016, respectively.
Ethics approval Oxfordshire REC C, approved on 04/09/2009 (ref: 09/H606/88)
Study design Multicentre prospective superiority randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Osteoarthritis/ avascular necrosis
Participants - inclusion criteria 1. Medial osteoarthritis with exposed bone on both femur and tibia or avascular necrosis
2. Functionally intact anterior cruciate ligament (superficial damage or splitting is acceptable)
3. Full thickness lateral cartilage
4. Correctable intra-articular varus deformity (suggestive of functionally intact medical cruciate ligament)
5. Medically fit showing an American Society of Anaesthesiologists (ASA) grade 1 or 2
6. Expectancy of over 10 years of active life
7. Aged 40 years or over, either sex
Participants - exclusion criteria 1. Require revision knee replacement surgery
2. Have rheumatoid arthritis or other inflammatory disorders
3. Are likely to benefit from a specific prosthesis type
4. Are unlikely to be able to perform required clinical assessment tasks
5. Have symptomatic foot, hip or spinal pathology
Anticipated start date 01/11/2009
Anticipated end date 31/10/2016
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 500
Interventions Total knee replacement surgery versus unicompartmental knee replacement surgery. Patients will be followed up for 10 years post surgery. Going on the average waiting list times of 3 months, the approximate involvement in the study for each participant (recruitment, treatment and follow up) would be 10 years and 3 months.
Primary outcome measure(s) Oxford Knee Score: a patient based validated and effective measure of change over time questionnaire. Both the absolute and the change scores will be analysed at 5- and 10-year points post-operation.
Secondary outcome measure(s) 1. American Knee Society Score: to measure the range of motion and function of the knee, measured at 2 months, 1, 5 and 10 years post-surgery
2. UCLA Activity Score: to measure how active the patient is, measured at 2 months, 1, 5 and 10 years post-surgery
3. X-ray to check for immediate problems, assess the outcome of surgery, complications and make long-term predictions, measured at 2 months, 1, 5 and 10 years post-surgery
4. EQ-5D: to provide data for the economic evaluation, measured at 2 months, 1, 2, 3, 4, 5, 7 and 10 years post-surgery
5. Lund Score: to measure patient satisfaction, measured at 2 months, 1, 2, 3, 4, 5, 7 and 10 years post-surgery
6. Other outcomes, e.g., kinematic and gait assessments, measured at 2 months, 1, 5 and 10 years post-surgery
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications
Contact name Dr  David  Beard
  Address Nuffield Department of Orthopaedic, Rheumatology & Musculoskeletal Sciences
Windmill Road
Headington
  City/town Oxford
  Zip/Postcode OX3 7LD
  Country United Kingdom
  Tel +44 (0)1865 227695
  Fax +44 (0)1865 227671
  Email david.beard@ndorms.ox.ac.uk
Sponsor University of Oxford (UK)
  Address Clinical Trials and Research Governance Unit
Manor House
John Radcliffe Hospital
Headington
  City/town Oxford
  Zip/Postcode OX3 9DZ
  Country United Kingdom
  Tel +44 (0)1865 743002
  Email heather.house@admin.ox.ac.uk
  Sponsor website: http://www.admin.ox.ac.uk/rso/clinical
Date applied 08/04/2009
Last edited 22/09/2009
Date ISRCTN assigned 09/04/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central